Avid Bioservices Inc (CDMO)

[entdoc]

2ndstr:Bottomline: you are aluding to my post of 01/17/15,: "I know it is beating a dead horse, but I am still a believer in Cotara concept, of more precise delivery of I131 to tumor site. It looks now as if more than one MAB is capable of doing that (including Bavi?), but now the fascination is with immunomodulators which may well work in combination therapy in early disease, but it still takes a bomb to shrink large, bulky tumors which, with earlier diagnosis and intervention, will hopefully go the way of Cotara. However, with the way 3rd party intervention is going, I am not certain that in the near future we are going to see a decreased incidence of large bulky tumors at time of presentation to a physician. All this is a longwinded defense of a Cotara-like MAB. I would still like to see what the Chinese came up with in their trials of Cotara in lung cancer. Apparently it was nothing remarkable. Cheers!"
So, 2ndstr, I ask again, "What evidence is there ANYwhere that Cotara, or similar, is being used anywhere for ANYthing, especially in China for lung cancer?